Related Experiment Video
Updated: Jun 21, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Impact effects of puerarin on mouse embryonic development
Chia-Chi Chen1, Wen-Hsiung Chan
1Department of Bioscience Technology and Center for Nanotechnology, Chung Yuan Christian University, Chung Li 32023, Taiwan.
Reproductive Toxicology (Elmsford, N.Y.)
|August 4, 2009
Summary
Puerarin exposure increased apoptosis in mouse blastocysts. While implantation rates were unaffected, post-implantation development was hindered, suggesting potential risks for early embryonic development.
Area of Science:
- Reproductive Biology
- Developmental Toxicology
- Pharmacology
Background:
- Puerarin is an isoflavone with potential biological activities.
- Understanding its effects on early embryonic development is crucial.
Purpose of the Study:
- To investigate the cytotoxic effects of puerarin on mouse blastocysts.
- To assess puerarin's impact on in vitro and in vivo embryonic development and implantation.
Main Methods:
- Mouse blastocysts were exposed to varying concentrations of puerarin (2.5, 5, 10 microM).
- Apoptosis was assessed using TUNEL assay; cell proliferation was evaluated by differential staining.
- In vitro development and in vivo embryo transfer were used to measure implantation and post-implantation outcomes.
Main Results:
- Puerarin (5 and 10 microM) significantly increased blastocyst apoptosis and decreased cell number.
- No significant difference in implantation success rate was observed.
- Post-implantation, increased embryo resorption and reduced fetal weight were noted with puerarin treatment.
Conclusions:
- In vitro puerarin exposure induces apoptosis in blastocysts.
- Puerarin exposure retards early post-implantation development in vivo.
- Further research is needed to determine puerarin's teratogenic potential in human development.
